AVEO Pharmaceuticals (AVEO) stock is up 18.7% Thursday. AVEO stock is lower by -65.26% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AVEO stock a score of 41 out of a possible 100.
That score is primarily influenced by a long-term technical score of 16. AVEO’s score also includes a short-term technical score of 38. The fundamental score for AVEO is 67. In addition to the average rating from Wall Street analysts, AVEO stock has a mean target price of $1.75. This means analysts expect the stock to add 136.49% over the next 12 months.
What’s Happening with AVEO Stock Today
AVEO Pharmaceuticals, Inc. (AVEO) stock has gained 18.7% while the S&P 500 is up 1% as of 12:59 PM on Thursday, Aug 1. AVEO is up $0.12 from the previous closing price of $0.62 on volume of 13,337,640 shares. Over the past year the S&P 500 is higher by 6.89% while AVEO is lower by -65.26%. AVEO lost -$0.04 per share in the over the last 12 months.